{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:44Z","timestamp":1791928904492,"version":"4.3.4"},"reference-count":59,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,7,2]]},"DOI":"10.1167\/iovs.67.8.4","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:30:45Z","timestamp":1782995445000},"page":"4","source":"Crossref","is-referenced-by-count":0,"title":["Proteomic Profiling of Optic Nerves From SMOX-Deficient Mice Identifies Regulators of Neuroinflammation and Axonal Damage in Optic Neuritis"],"prefix":"10.1167","volume":"67","author":[{"given":"Harry","family":"Henry Ojo","sequence":"first","affiliation":[{"name":"Clinical and Experimental Therapeutics, University of Georgia, Augusta, Georgia, United States"},{"name":"Augusta University Culver Vision Discovery Institute, Augusta, Georgia, United States"},{"name":"VA Augusta Health Care System, Augusta, Georgia, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Therapeutics, University of Georgia, Augusta, Georgia, United States"},{"name":"Augusta University Culver Vision Discovery Institute, Augusta, Georgia, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz H.","family":"Alanazi","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Therapeutics, University of Georgia, Augusta, Georgia, United States"},{"name":"VA Augusta Health Care System, Augusta, Georgia, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar A.","family":"Zahedi","sequence":"additional","affiliation":[{"name":"University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States"},{"name":"Research Services, New Mexico Veterans Health Care System, Albuquerque, New Mexico, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoocher","family":"Soleimani","sequence":"additional","affiliation":[{"name":"University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States"},{"name":"Research Services, New Mexico Veterans Health Care System, Albuquerque, New Mexico, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Therapeutics, University of Georgia, Augusta, Georgia, United States"},{"name":"VA Augusta Health Care System, Augusta, Georgia, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payaningal R.","family":"Somanath","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Therapeutics, University of Georgia, Augusta, Georgia, United States"},{"name":"Augusta University Culver Vision Discovery Institute, Augusta, Georgia, United States"},{"name":"VA Augusta Health Care System, Augusta, Georgia, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Priya","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Therapeutics, University of Georgia, Augusta, Georgia, United States"},{"name":"Augusta University Culver Vision Discovery Institute, Augusta, Georgia, United States"},{"name":"VA Augusta Health Care System, Augusta, Georgia, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"3","key":"bib1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrneurol.2010.1","article-title":"Environmental factors and their timing in adult-onset multiple sclerosis","volume":"6","author":"Handel","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"bib2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2012.01134.x","article-title":"The genetics of multiple sclerosis: an up-to-date review","volume":"248","author":"Gourraud","year":"2012","journal-title":"Immunol Rev"},{"issue":"2","key":"bib3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1573395511666150707181644","article-title":"Optic neuritis: a model for the immuno-pathogenesis of central nervous system inflammatory demyelinating diseases","volume":"11","author":"Wu","year":"2015","journal-title":"Curr Immunol Rev"},{"issue":"6","key":"bib4","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","author":"Optic Neuritis Study Group","year":"2008","journal-title":"Arch Neurol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/EB.S54131","article-title":"Optic neuritis as an early sign of multiple sclerosis","volume":"8","author":"Kale","year":"2016","journal-title":"Eye Brain"},{"issue":"12","key":"bib6","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.apmr.2020.08.003","article-title":"Vision problems in multiple sclerosis","volume":"101","author":"Costa","year":"2020","journal-title":"Arch Phys Med Rehabil"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.msard.2018.06.011","article-title":"Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: a case report","volume":"24","author":"Giordano","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"bib8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/WNO.0b013e318238937f","article-title":"Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection","volume":"31","author":"Sakai","year":"2011","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"bib9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1212\/WNL.43.4.662","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"issue":"9","key":"bib10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"bib11","doi-asserted-by":"publisher","first-page":"e7624","DOI":"10.1371\/journal.pone.0007624","article-title":"Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage","volume":"4","author":"Linker","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"bib12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"bib13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1750-3639.2005.tb00094.x","article-title":"Gene and protein expression profiling of the microvascular compartment in experimental autoimmune encephalomyelitis in C57Bl\/6 and SJL mice","volume":"15","author":"Alt","year":"2005","journal-title":"Brain Pathol"},{"issue":"1","key":"bib14","doi-asserted-by":"publisher","first-page":"21793","DOI":"10.1038\/s41598-024-67769-1","article-title":"Targeted proteomics of cerebrospinal fluid in treatment na\u00efve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes","volume":"14","author":"Rabin","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"bib15","doi-asserted-by":"publisher","first-page":"e200322","DOI":"10.1212\/NXI.0000000000200322","article-title":"Proteomics reveals age as major modifier of inflammatory CSF signatures in multiple sclerosis","volume":"12","author":"Held","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"bib16","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1021\/pr070012k","article-title":"Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord","volume":"6","author":"Liu","year":"2007","journal-title":"J Proteome Res"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1038\/s41598-021-86191-5","article-title":"Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis","volume":"11","author":"Oveland","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"bib18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/biom15020158","article-title":"Targeting SMOX preserves optic nerve myelin, axonal integrity, and visual function in multiple sclerosis","volume":"15","author":"Henry-Ojo","year":"2025","journal-title":"Biomolecules"},{"issue":"24","key":"bib19","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.3390\/cells11244100","article-title":"Treatment with MDL 72527 ameliorated clinical symptoms, retinal ganglion cell loss, optic nerve inflammation, and improved visual acuity in an experimental model of multiple sclerosis","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"issue":"2","key":"bib20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/toxsci\/kfy300","article-title":"Targeting Smox is neuroprotective and ameliorates brain inflammation in cerebral ischemia\/reperfusion rats","volume":"168","author":"Fan","year":"2019","journal-title":"Toxicol Sci"},{"issue":"9","key":"bib21","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1007\/s12035-017-0864-0","article-title":"Glutamate excitotoxicity linked to spermine oxidase overexpression","volume":"55","author":"Pietropaoli","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"9","key":"bib22","doi-asserted-by":"publisher","first-page":"e0184570","DOI":"10.1371\/journal.pone.0184570","article-title":"Activation of endoplasmic reticulum stress response by enhanced polyamine catabolism is important in the mediation of cisplatin-induced acute kidney injury","volume":"12","author":"Zahedi","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"bib23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12974-020-01955-6","article-title":"Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia","volume":"17","author":"Zahedi","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"2","key":"bib24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/jcm9020340","article-title":"Pharmacological inhibition of spermine oxidase reduces neurodegeneration and improves retinal function in diabetic mice","volume":"9","author":"Liu","year":"2020","journal-title":"J Clin Med"},{"issue":"12","key":"bib25","doi-asserted-by":"publisher","first-page":"8589","DOI":"10.1007\/s12035-019-01691-w","article-title":"Deletion of arginase 2 ameliorates retinal neurodegeneration in a mouse model of multiple sclerosis","volume":"56","author":"Palani","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"11","key":"bib26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nmeth1113","article-title":"Semi-supervised learning for peptide identification from shotgun proteomics datasets.","volume":"4","author":"K\u00e4ll","year":"2007","journal-title":"Nat Methods."},{"key":"bib27","doi-asserted-by":"publisher","first-page":"620963","DOI":"10.3389\/fimmu.2021.620963","article-title":"Platelets in multiple sclerosis: early and central mediators of inflammation and neurodegeneration and attractive targets for molecular imaging and site-directed therapy","volume":"12","author":"Orian","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"bib28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41419-018-1294-2","article-title":"Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology","volume":"10","author":"Derada Troletti","year":"2019","journal-title":"Cell Death Dis"},{"issue":"3","key":"bib29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00441-014-1811-2","article-title":"Novel insights into the development and maintenance of the blood\u2013brain barrier","volume":"355","author":"Engelhardt","year":"2014","journal-title":"Cell Tissue Res"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"117521","DOI":"10.1016\/j.biopha.2024.117521","article-title":"Disruption of blood\u2013brain barrier and endothelial-to-mesenchymal transition are attenuated by Astragalus polysaccharides mediated through upregulation of ETS1 expression in experimental autoimmune encephalomyelitis","volume":"180","author":"Lu","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"bib31","first-page":"20552173251346979","article-title":"Blood\u2013brain barrier permeability in relation to disease severity and timing of multiple sclerosis diagnosis in optic neuritis","volume":"11","author":"Passali","year":"2025","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"pt 9","key":"bib32","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/brain\/awv203","article-title":"Permeability of the blood\u2013brain barrier predicts conversion from optic neuritis to multiple sclerosis","volume":"138","author":"Cramer","year":"2015","journal-title":"Brain"},{"issue":"4","key":"bib33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.stemcr.2023.02.012","article-title":"Viral delivery of L1CAM promotes axonal extensions by embryonic cerebral grafts in mouse brain","volume":"18","author":"Tsuchimochi","year":"2023","journal-title":"Stem Cell Reports"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"625340","DOI":"10.3389\/fcell.2021.625340","article-title":"Molecular mechanisms of L1 and NCAM adhesion molecules in synaptic pruning, plasticity, and stabilization","volume":"9","author":"Duncan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"105644","DOI":"10.1016\/j.msard.2024.105644","article-title":"Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis","volume":"87","author":"Koerbel","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"bib36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10072-012-0974-4","article-title":"Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis","volume":"34","author":"Madeddu","year":"2013","journal-title":"Neurol Sci"},{"issue":"8","key":"bib37","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4103\/1673-5374.162691","article-title":"Distribution pattern of axonal cytoskeleton proteins in the human optic nerve head","volume":"10","author":"Kang","year":"2015","journal-title":"Neural Regen Res"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fimmu.2016.00449","article-title":"TCR triggering induces the formation of Lck\u2013RACK1\u2013actinin-1 multiprotein network affecting Lck redistribution","volume":"7","author":"Ballek","year":"2016","journal-title":"Front Immunol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"603710","DOI":"10.3389\/fncel.2020.603710","article-title":"Autophagy in multiple sclerosis: two sides of the same coin","volume":"14","author":"Misrielal","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"bib40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.gene.2016.04.042","article-title":"Gene expression profiles of autophagy-related genes in multiple sclerosis","volume":"588","author":"Igci","year":"2016","journal-title":"Gene"},{"issue":"5","key":"bib41","doi-asserted-by":"publisher","first-page":"37838","DOI":"10.31083\/FBL37838","article-title":"HMGB1 mediates microglia\u2013astrocyte\/neuron crosstalk and pyroptosis by the TLR4\/NF-?B pathway in multiple sclerosis","volume":"30","author":"Feng","year":"2025","journal-title":"Front Biosci (Landmark Ed)"},{"key":"bib42","first-page":"30264","article-title":"Annexin A1, calreticulin and high mobility group box 1 are elevated in secondary progressive multiple sclerosis: does immunogenic cell death occur in multiple sclerosis?","volume":"15","author":"Hejazi","year":"2025","journal-title":"Bioimpacts"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"584097","DOI":"10.3389\/fimmu.2021.584097","article-title":"HMGB1 promotes the release of sonic hedgehog from astrocytes","volume":"12","author":"Xiao","year":"2021","journal-title":"Front Immunol"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"1029891","DOI":"10.3389\/fneur.2022.1029891","article-title":"HMGB1 in nervous system diseases: a common biomarker and potential therapeutic target","volume":"13","author":"Mao","year":"2022","journal-title":"Front Neurol"},{"issue":"1","key":"bib45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/0028-3886.338707","article-title":"Does the serum expression level of high-mobility group box 1 (HMGB1) in multiple sclerosis patients have a relationship with physical and psychological status? A 12-month follow-up study on newly diagnosed MS patients","volume":"70","author":"Sharafkhah","year":"2022","journal-title":"Neurol India"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"1569632","DOI":"10.3389\/fimmu.2025.1569632","article-title":"HMGB1: new biomarker and therapeutic target of autoimmune and autoinflammatory skin diseases","volume":"16","author":"Fan","year":"2025","journal-title":"Front Immunol"},{"issue":"12","key":"bib47","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.3390\/ijms23126715","article-title":"High-mobility group box 1 inhibitor BoxA alleviates neuroinflammation-induced retinal ganglion cell damage in traumatic optic neuropathy","volume":"23","author":"Peng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/EB.S352730","article-title":"Involvement of high mobility group box 1 protein in optic nerve damage in diabetes","volume":"14","author":"Mohammad","year":"2022","journal-title":"Eye Brain"},{"issue":"8","key":"bib49","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/biom15081125","article-title":"Relationship of S100 proteins with neuroinflammation","volume":"15","author":"Garc\u00eda-Dom\u00ednguez","year":"2025","journal-title":"Biomolecules"},{"issue":"6","key":"bib50","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1007\/s12035-015-9336-6","article-title":"S100B as a potential biomarker and therapeutic target in multiple sclerosis","volume":"53","author":"Barateiro","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"pt A","key":"bib51","doi-asserted-by":"crossref","first-page":"112849","DOI":"10.1016\/j.intimp.2024.112849","article-title":"S100A4 promotes experimental autoimmune encephalomyelitis by impacting microglial inflammation through TLR4\/NF-?B signaling pathway","volume":"142","author":"Jingjing","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"104299","DOI":"10.1016\/j.phrs.2019.104299","article-title":"Spermine oxidase: a promising therapeutic target for neurodegeneration in diabetic retinopathy","volume":"147","author":"Narayanan","year":"2019","journal-title":"Pharmacol Res."},{"key":"bib53","doi-asserted-by":"publisher","first-page":"111183","DOI":"10.1016\/j.intimp.2023.111183","article-title":"Knockdown of Smox protects the integrity of the blood-brain barrier through antioxidant effect and Nrf2 pathway activation in stroke","volume":"126","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"bib54","doi-asserted-by":"publisher","first-page":"14841","DOI":"10.1038\/s41598-017-14929-1","article-title":"Spermine oxidase promotes bile canalicular lumen formation through acrolein production","volume":"7","author":"Uemura","year":"2017","journal-title":"Sci Rep."},{"issue":"4","key":"bib55","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.3390\/ijms23042133","article-title":"Pharmacological inhibition of spermine oxidase suppresses excitotoxicity induced neuroinflammation in mouse retina","volume":"23","author":"Alfarhan","year":"2022","journal-title":"Int J Mol Sci."},{"key":"bib56","doi-asserted-by":"publisher","first-page":"1448215","DOI":"10.3389\/fnmol.2024.1448215","article-title":"Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions","volume":"17","author":"Wilkins","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fnins.2015.00264","article-title":"The unfolded protein response in multiple sclerosis","volume":"9","author":"Stone","year":"2015","journal-title":"Front Neurosci"},{"issue":"1","key":"bib58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s40478-023-01705-8","article-title":"Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration","volume":"11","author":"Zhao","year":"2023","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"bib59","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/prca.200700315","article-title":"Proteomic strategies in multiple sclerosis and its animal models","volume":"1","author":"Elkabes","year":"2007","journal-title":"Proteomics Clin Appl"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.8.4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:19Z","timestamp":1791927139000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.8.4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.8.4","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}